Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

OrthoPediatrics Corp. KIDS

Healthcare  —  Medical Devices
22.55 (0.09) (0.40%) as of 25 Sep
Market cap
$591.1M
P/E
0.0×
Revenue Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

OrthoPediatrics Corp. (KIDS) Business Profile

Updated before January 2025

Company Overview

OrthoPediatrics Corp. (NASDAQ: KIDS) is a leading medical device company dedicated to advancing the field of pediatric orthopedics. Founded in 2006 and headquartered in Warsaw, Indiana, OrthoPediatrics was established with the mission of improving the lives of children with orthopedic conditions. The company is unique in its exclusive focus on pediatric patients, addressing a critical gap in the orthopedic market that historically catered primarily to adults.

The company was founded by Mark Throdahl, who recognized the need for specialized orthopedic solutions for children. Under his leadership, OrthoPediatrics has grown into a global leader in pediatric orthopedics. The company’s current leadership team includes David Bailey, who serves as President and Chief Executive Officer, and Fred Hite, the Chief Financial Officer. Together, they have steered the company toward innovation and growth, ensuring its position as a trusted partner for pediatric orthopedic surgeons worldwide.

Core Business Segments

OrthoPediatrics operates through three primary business segments, each focused on addressing specific needs within pediatric orthopedics:

1. Trauma and Deformity Correction

This segment includes a wide range of products designed to treat fractures, deformities, and other orthopedic conditions in children. Key products include:

  • PediLoc® System: A comprehensive system for pediatric trauma and deformity correction, offering anatomically appropriate implants and instruments.
  • Response® Spine System: A versatile system for treating complex spinal deformities in children.
  • OrthoPediatrics Locking Cannulated Blade Plate System: Designed for precise correction of deformities.

2. Scoliosis

OrthoPediatrics provides innovative solutions for the treatment of scoliosis, a condition that affects the curvature of the spine. Key products include:

  • ApiFix® System: A minimally invasive solution for treating adolescent idiopathic scoliosis (AIS).
  • Response® Spine System: A modular system designed for spinal deformity correction.
  • BandLoc® System: A band-based fixation system for scoliosis treatment.

3. Sports Medicine/Other

This segment focuses on addressing sports-related injuries and other orthopedic conditions in children. Key offerings include:

  • PediPlates®: A growth modulation system for correcting angular deformities.
  • QuickPack® Bone Void Filler: A solution for filling bone voids during surgical procedures.
  • Soft Tissue Repair Solutions: Products designed for ligament and tendon repair in pediatric patients.

Business Model

OrthoPediatrics operates a highly specialized business model that integrates product innovation, surgeon education, and global distribution. The company collaborates closely with pediatric orthopedic surgeons to develop products tailored to the unique needs of children. This surgeon-centric approach ensures that the company’s offerings are both clinically effective and user-friendly.

Revenue generation primarily comes from the sale of implants, instruments, and related surgical tools. OrthoPediatrics also invests heavily in surgeon education and training, hosting workshops and seminars to ensure the effective use of its products. The company’s global distribution network spans over 40 countries, enabling it to reach pediatric patients worldwide.

Strategic Direction

OrthoPediatrics is committed to expanding its product portfolio and geographic reach. Key strategic initiatives include:

  • Product Innovation: The company continues to invest in research and development to introduce new and improved solutions for pediatric orthopedics. Recent innovations include the ApiFix® System and advancements in the Response® Spine System.
  • Geographic Expansion: OrthoPediatrics aims to strengthen its presence in international markets, particularly in Europe and Asia.
  • Sustainability Goals: The company is focused on reducing its environmental footprint by adopting sustainable manufacturing practices and minimizing waste.
  • Acquisitions and Partnerships: OrthoPediatrics actively seeks strategic acquisitions and partnerships to enhance its product offerings and market presence.

Competitive Landscape

OrthoPediatrics operates in a niche market with limited direct competition. However, it faces indirect competition from larger orthopedic companies that offer pediatric products as part of their broader portfolios. Key competitors include:

  • Zimmer Biomet: Offers a range of orthopedic solutions, including pediatric implants.
  • Stryker Corporation: Provides pediatric orthopedic products through its trauma and extremities division.
  • DePuy Synthes (a Johnson & Johnson company): Offers pediatric trauma and deformity correction solutions.

Despite this competition, OrthoPediatrics differentiates itself through its exclusive focus on pediatric orthopedics and its surgeon-centric approach.

Risk Factors

Like any business, OrthoPediatrics faces several risks that could impact its operations and financial performance:

  • Market Dependence: The company’s revenue is heavily reliant on the sale of pediatric orthopedic products. Any decline in demand could adversely affect its financial performance.
  • Supply Chain Disruptions: Global supply chain challenges could impact the availability of raw materials and components, leading to production delays.
  • Regulatory Risks: The company operates in a highly regulated industry, and changes in regulatory requirements could increase compliance costs.
  • Competition: While OrthoPediatrics operates in a niche market, it faces competition from larger, well-established orthopedic companies.

Recent Developments

OrthoPediatrics has made significant strides in recent years, including:

  • ApiFix® System Approval: The company received FDA approval for its ApiFix® System, a minimally invasive solution for scoliosis treatment.
  • Acquisition of MD Orthopaedics: This acquisition expanded OrthoPediatrics’ product portfolio to include solutions for clubfoot treatment.
  • Global Expansion: The company has strengthened its presence in international markets, with new distribution agreements in Europe and Asia.
  • COVID-19 Impact: While the pandemic initially disrupted elective surgeries, OrthoPediatrics has seen a strong recovery in demand for its products.

Investment Considerations

Strengths:

  • Exclusive focus on pediatric orthopedics, a niche market with significant growth potential.
  • Strong track record of innovation and product development.
  • Global distribution network and surgeon-centric approach.
  • Robust financial performance and growth prospects.

Risks:

  • Dependence on a single market segment (pediatric orthopedics).
  • Exposure to regulatory and supply chain risks.
  • Competition from larger orthopedic companies.

Conclusion

OrthoPediatrics Corp. is a pioneer in the field of pediatric orthopedics, offering innovative solutions that improve the lives of children worldwide. With a strong focus on product innovation, surgeon education, and global expansion, the company is well-positioned for future growth. While it faces certain risks, its unique market position and commitment to excellence make it an attractive investment opportunity for those seeking exposure to the healthcare sector.